CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Polus BioPharm Inc Company Snapshot
Polus BioPharm Inc operates within the Telephone and telegraph apparatus sector. In addition to historical fundamental analyses, the complete report available to purchase compares Polus BioPharm Inc with three other companies in this sector in South Korea: Frtek Company Limited (2017 sales of 23.22 billion Korean Won [US$20.68 million] ), Piolink Inc (29.43 billion Korean Won [US$26.22 million] ), and YW Co Ltd (23.47 billion Korean Won [US$20.91 million] ).

Sales Analysis. During the year ended December of 2017, sales at Polus BioPharm Inc were 29.62 billion Korean Won (US$26.39 million). This is a decrease of 7.1% versus 2016, when the company's sales were 31.90 billion Korean Won.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Polus BioPharm Inc
  Stock Performance Chart for Polus BioPharm Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (12/7/2018): 6,500.00
(Figures in Korean Won)
1 Week -12.2%   13 Weeks -28.6%  
4 Weeks -58.7%   52 Weeks 16.3%  
 
Polus BioPharm Inc Key Data:
  Ticker: 007630 Country: Korea (South)
  Exchanges: SEO Major Industry: Communications Equipment
    Sub Industry: Telephone & Telegraph Apparatus
  2017 Sales 29,622,794,893
(Year Ending Jan 2018).
Employees: 148
  Currency: Korean Won Market Cap: 205,508,673,500
  Fiscal Yr Ends: December Shares Outstanding: 31,616,719
  Share Type: Common Closely Held Shares: 15,050,471
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.